Close

HIV-1 gag

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Matrix protein p17: Targets the polyprotein to the plasma membrane via a multipartite membrane-binding signal, that includes its myristoylated N-terminus. Matrix protein is part of the pre-integration complex. Implicated in the release from host cell mediated by Vpu. Binds to RNA
  • TCR Cell Products

Loading...
  • Cell Type:
  • Target:
  • HLA:
  • Epitope:
CAT Product Name Cell Type Target HLA Epitope Inquiry & Datasheet
TCRJ-CQ119 Anti-HIV-1 gag (SLYNTVATL) T Cell Receptor (clone C-4), Jurkat Cell Line T lymphocyte HIV-1 gag HLA-A2 SLYNTVATL   Add to Cart   Datasheet
TCRJ-CQ122 Anti-HIV-1 gag (SLYNTVATL) T Cell Receptor (clone HIV-A2-SL9), Jurkat Cell Line T lymphocyte HIV-1 gag HLA-A2 SLYNTVATL   Add to Cart   Datasheet
TCRJ-CQ123 Anti-HIV-1 gag (KRWIILGLNK) T Cell Receptor (clone HIV-B27-KK10), Jurkat Cell Line T lymphocyte HIV-1 gag HLA-B27 KRWIILGLNK   Add to Cart   Datasheet
TCRJ-CQ124 Anti-HIV-1 gag (KAFSPEVIPMF) T Cell Receptor (clone HIV-B57-KF11), Jurkat Cell Line T lymphocyte HIV-1 gag HLA-B57 KAFSPEVIPMF   Add to Cart   Datasheet
TCRJ-CQ125 Anti-HIV-1 gag (TSTLQEQIGW) T Cell Receptor (clone HIV-B57-TW10), Jurkat Cell Line T lymphocyte HIV-1 gag HLA-B57 TSTLQEQIGW   Add to Cart   Datasheet
TCRJ-CQ126 Anti-HIV-1 gag (SEGATPQDL) T Cell Receptor (clone HIV-B60-SL9), Jurkat Cell Line T lymphocyte HIV-1 gag HLA-B60 SEGATPQDL   Add to Cart   Datasheet
TCRJ-CQ127 Anti-HIV-1 gag (EIYKRWII) T Cell Receptor (clone HIV-B8-EI8), Jurkat Cell Line T lymphocyte HIV-1 gag HLA-B8 EIYKRWII   Add to Cart   Datasheet
XS-0623-ZP152 Anti-HIV-1 gag TCR-NK Cells TCR-NK HIV-1 gag   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.